AbbVie Inc. Effective Tax Rate
AbbVie Inc. (ABBV) reported Effective Tax Rate of 15.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-03
- AbbVie Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 15.00%, a 61.54% decline year-over-year.
- AbbVie Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 33.00%, a 50.00% increase year-over-year.
- AbbVie Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 74.00%, a 196.00% increase year-over-year.
- AbbVie Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 39.00%, a 8.33% increase year-over-year.
- AbbVie Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 35.80%.
- AbbVie Inc. effective income tax rate reconciliation, percent for fiscal 2024 was -15.30%, a 169.55% decline from fiscal 2023.
- AbbVie Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 22.00%, a 81.82% increase from fiscal 2022.
- AbbVie Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 12.10%, a 9.01% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.00% 10-Q · filed 2026-08-03 | 19.00% 10-Q · filed 2026-08-03 | |||||
| 2026-03-31 | 33.00% 10-Q · filed 2026-05-08 | ||||||
| 2025-12-31 | 35.80% 10-K · filed 2026-02-20 | ||||||
| 2025-09-30 | 74.00% 10-Q · filed 2025-11-04 | 39.00% 10-Q · filed 2025-11-04 | |||||
| 2025-06-30 | 39.00% 10-Q · filed 2026-08-03 | 31.00% 10-Q · filed 2026-08-03 | |||||
| 2025-03-31 | 22.00% 10-Q · filed 2026-05-08 | ||||||
| 2024-12-31 | -15.30% 10-K · filed 2026-02-20 | ||||||
| 2024-09-30 | 25.00% 10-Q · filed 2025-11-04 | 28.00% 10-Q · filed 2025-11-04 | |||||
| 2024-06-30 | 36.00% 10-Q · filed 2025-08-04 | 30.00% 10-Q · filed 2025-08-04 | |||||
| 2024-03-31 | 22.00% 10-Q · filed 2025-05-09 | ||||||
| 2023-12-31 | 22.00% 10-K · filed 2026-02-20 | ||||||
| 2023-09-30 | 9.00% 10-Q · filed 2024-11-04 | 20.00% 10-Q · filed 2024-11-04 | |||||
| 2023-06-30 | 22.00% 10-Q · filed 2024-08-07 | 26.00% 10-Q · filed 2024-08-07 | |||||
| 2023-03-31 | 49.00% 10-Q · filed 2024-05-03 | ||||||
| 2022-12-31 | 12.10% 10-K · filed 2025-02-14 | ||||||
| 2022-09-30 | 10.00% 10-Q · filed 2023-11-06 | 11.00% 10-Q · filed 2023-11-06 | |||||
| 2022-06-30 | 22.00% 10-Q · filed 2023-08-07 | 11.00% 10-Q · filed 2023-08-07 | |||||
| 2022-03-31 | 9.00% 10-Q · filed 2023-05-05 | ||||||
| 2021-12-31 | 11.10% 10-K · filed 2024-02-20 | ||||||
| 2021-09-30 | 14.00% 10-Q · filed 2022-11-04 | 14.00% 10-Q · filed 2022-11-04 | |||||
| 2021-06-30 | 34.00% 10-Q · filed 2022-08-04 | 14.00% 10-Q · filed 2021-08-02 | 14.00% 10-Q · filed 2022-08-04 | 34.00% 10-Q · filed 2021-08-02 | |||
| 2021-03-31 | 8.00% 10-Q · filed 2022-05-06 | ||||||
| 2020-12-31 | -36.00% 10-K · filed 2023-02-17 | ||||||
| 2020-09-30 | 7.00% 10-Q · filed 2021-11-02 | 7.00% 10-Q · filed 2021-11-02 | |||||
| 2020-06-30 | -7.00% 10-Q · filed 2021-08-02 | 6.00% 10-Q · filed 2021-08-02 | |||||
| 2020-03-31 | 3.00% 10-Q · filed 2021-05-07 | ||||||
| 2019-12-31 | 6.50% 10-K · filed 2022-02-18 | ||||||
| 2019-09-30 | 6.00% 10-Q · filed 2020-11-04 | 5.00% 10-Q · filed 2020-11-04 | |||||
| 2019-06-30 | 8.00% 10-Q · filed 2020-08-04 | 5.00% 10-Q · filed 2020-08-04 | |||||
| 2019-03-31 | 3.00% 10-Q · filed 2020-05-08 | ||||||
| 2018-12-31 | -9.40% 10-K · filed 2021-02-19 | ||||||
| 2018-09-30 | 1.00% 10-Q · filed 2019-11-06 | 1.00% 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | 2.00% 10-Q · filed 2019-08-05 | 1.00% 10-Q · filed 2019-08-05 | |||||
| 2018-03-31 | 1.00% 10-Q · filed 2019-05-03 | ||||||
| 2017-12-31 | 31.30% 10-K · filed 2020-02-21 | ||||||
| 2017-09-30 | 22.00% 10-Q · filed 2018-11-07 | 20.00% 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | 19.00% 10-Q · filed 2018-08-07 | 18.00% 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | 18.00% 10-Q · filed 2018-05-04 | ||||||
| 2016-12-31 | 24.50% 10-K · filed 2019-02-27 | ||||||
| 2016-09-30 | 21.00% 10-Q · filed 2017-11-07 | 22.00% 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | 23.00% 10-Q · filed 2017-08-07 | 23.00% 10-Q · filed 2017-08-07 | |||||
| 2016-03-31 | 24.00% 10-Q · filed 2017-05-05 | ||||||
| 2015-12-31 | 22.60% 10-K · filed 2018-02-16 | ||||||
| 2015-09-30 | 25.00% 10-Q · filed 2016-11-07 | 23.00% 10-Q · filed 2016-11-07 | |||||
| 2015-06-30 | 19.00% 10-Q · filed 2016-08-05 | 22.00% 10-Q · filed 2016-08-05 | |||||
| 2015-03-31 | 27.00% 10-Q · filed 2016-05-06 | ||||||
| 2014-12-31 | 25.10% 10-K · filed 2017-02-17 | ||||||
| 2014-09-30 | 26.00% 10-Q · filed 2015-11-06 | 26.30% 10-Q · filed 2014-11-07 | 24.00% 10-Q · filed 2015-11-06 | 24.10% 10-Q · filed 2014-11-07 | |||
| 2014-06-30 | 23.00% 10-Q · filed 2015-08-07 | 23.40% 10-Q · filed 2014-08-07 | 24.00% 10-Q · filed 2015-08-07 | 23.60% 10-Q · filed 2014-08-07 | |||
| 2014-03-31 | 24.00% 10-Q · filed 2015-05-08 | 23.80% 10-Q · filed 2014-05-09 | |||||
| 2013-12-31 | 22.60% 10-K · filed 2016-02-19 | ||||||
| 2013-09-30 | 25.00% 10-Q · filed 2014-11-07 | 22.90% 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | 21.90% 10-Q · filed 2014-08-07 | 21.90% 10-Q · filed 2014-08-07 | |||||
| 2013-03-31 | 21.90% 10-Q · filed 2014-05-09 | ||||||
| 2012-12-31 | 7.90% 10-K · filed 2015-02-20 | ||||||
| 2012-09-30 | 1.20% 10-Q · filed 2013-11-12 | 7.00% 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | 9.60% 10-Q · filed 2013-08-09 | 10.70% 10-Q · filed 2013-08-09 | |||||
| 2012-03-31 | 12.20% 10-Q · filed 2013-05-08 | ||||||
| 2011-12-31 | 6.40% 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |